Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence

BJU International

Volumn 101, Issue 9, 2008, Pages 1129-1134

  Mathers, Michael J ^a,e   Klotz, Theodor ^c   Brandt, Alexander S ^b   Roth, Stephan ^b   Sommer, Frank ^d  

^a Urological Ambulatory Remscheid ^*

^b University Medical Center Wiiten/Herdecke

^c Klinikum Weiden   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Urological Ambulatory   (Germany)

Author keywords

Daily dosing; Nocturnal penile tumescence and rigidity; Phosphodiesterase; Sexual dysfunction

Indexed keywords

SILDENAFIL; VARDENAFIL;

ADULT; ARTICLE; BEDTIME DOSAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG DOSE COMPARISON; DYSPEPSIA; ERECTILE DYSFUNCTION; EVENING DOSAGE; FLUSHING; HEADACHE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PARALLEL DESIGN; PENIS ERECTION; PENIS NOCTURNAL TUMESCENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION;

ADULT; AGED; HUMANS; IMIDAZOLES; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES; PURINES; SULFONES; TIME FACTORS; TREATMENT OUTCOME; TRIAZINES;

EID: 41849129285     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07376.x     Document Type: Article

References (24)

1. Christiansen E, Guirguis WR, Cox D, Osterloh IH. Long-term efficacy and safety of oral Viagra (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal. Int J Impot Res 2000 12 : 177 82
2. Saenz de Tejada I, Gonzales Cadavid N, Heaton J et al. Anatomy, physiology and pathophysiology of erectile dysfunction. In Jardin A, Wagner G, Khoury AE, Giuliano F, Padma-Nathan H, Rosen RC, Erectile Dysfunction. Plymouth : Health Publications Ltd, 2000 : 65 102
3. Terradas C, Levalle O, Nagelberg A, Mormandi E. Sildenafil improves nocturnal penile erections in organic impotence. Int J Impot Res 2001 13 : 125 9
4. Katz SD, Balidemaj K, Homma S, Wu H, Wang J, Maybaum S. Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol 2000 36 : 845 51
5. Desouza C, Parulkar A, Lumpkin D, Akers D, Fonseca VA. Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care 2002 25 : 1336 9
6. Montorsi F, Maga T, Strambi LF et al. Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 2000 56 : 906 11
7. Rochira V, Granata AR, Balestrieri A, Madeo B, Carani C. Effects of sildenafil on nocturnal penile tumescence and rigidity in normal men: randomized, placebo-controlled, crossover study. J Androl 2002 23 : 566 71
8. Sommer F, Klotz T, Engelmann U. Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial. Asian J Androl 2007 9 : 134 41
9. Bradley WE, Timm GW, Gallagher JM, Johnson BK. New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology 1985 26 : 4 9
10. Levine LA, Lenting EL. Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction. Urol Clin North Am 1995 22 : 775 88
11. Jünemann KP, Weiske WH. Duplex- und Farbduplexsonographie der penilen Gefäße S. In von Jünemann KP, Weiske WH, Dopplersonographie in der Urologie. New York : Medizin VCH, 1991 : 48 72
12. Rashid A. The efficacy and safety of PDE5 inhibitors. Clin Cornerstone 2005 7 : 47 56
13. van Lankveld JJ, van den Hout MA, Spigt MG, van Koeveringe GA. Cognitive changes predict continued recovery of erectile functioning versus relapse after discontinuation of sildenafil treatment for male erectile dysfunction. Psychosom Med 2003 65 : 709 18
14. Mirone V, Costa P, Damber J-E et al. An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries. Eur Urol 2005 47 : 846 54
15. McMahon C. Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatmnent of erectile dysfunction. J Sex Med 2005 2 : 415 27
16. Rosano GM, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005 47 : 214 20
17. Fisher C, Gorss J, Zuch J. Cycle of penile erection synchronous with dreaming (REM) sleep: preliminary report. Arch Gen Psychiatry 1965 12 : 29 45
18. Karacan I, Hursch CJ, Williams RL. Some characteristics of nocturnal penile tumescence in elderly males. J Gerontol 1972 27 : 39 45
19. Wagner G. Erection: anatomy. In Wagner G, Green R, Impotence: Physiological, Psychological, Surgical Diagnosis and Treatment. New York : Plenum Press, 1981 : 7 24
20. Ryu JK, Song SU, Choi HK et al. Plasma transforming growth factor-beta1 levels in patients with erectile dysfunction. Asian J Androl 2004 6 : 349 53
21. Padma-Nathan H, McCullough AR, Giuliano F, Toler SM, Wohlhuter C, Shpilsky AB. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003 169 (Suppl. 375 6
22. Karacan I, Karatas M. Erectile dysfunction in sleep apnea and response to CPAP. J Sex Marital Ther 1995 21 : 239 47
23. Sommer F, Peters C, Klotz T, Michna H, Schoenenberger A, Engelmann U. [Sport und Bewegund in der Pravention Urologischer Erkrankugen]. Urologe [B] 2002 42 : 297 305
24. Park K, Ahn KY, Kim MK, Lee SE, Kang TW, Ryu SB. Intracavernosal injection of vascular endothelial growth factor improves erectile function in aged rats. Eur Urol 2004 46 : 403 7